Katinka Van de Ven, Ph.D.
Dr. Katinka van de Ven is a Research Fellow as part of the Drug Policy Modelling Program (DPMP) at the Social Policy Research Centre (SPRC). Her current work is focused on how funding arrangements, purchasing mechanisms and workforce characteristics of alcohol and other drug (AOD) treatment agencies impacts on client outcomes (the Horizons project). She specialises in the use and supply of performance and image enhancing drugs (PIEDs), which includes projects surrounding the prevention of PIED use, harm reduction policies and improving healthcare services for users. Additionally, Dr. van de Ven also conducts research concerned with translating empirical evidence regarding the use and supply of PIEDs into useful information for healthcare professionals, decision makers, and other stakeholders.
Dr. Van de Ven's recent publications include:
- Van de Ven, K., Dunn, M., & Mulrooney, K. (2020). Human enhancement drugs and new(?) research directions. Performance Enhancement & Health, 7. DOI: 10.1016/j.peh.2020.100160.
- Thomas, N., Van de Ven, K., & Mulrooney, K. (2019). The impact of rurality on opioid-related harms: A systematic review of qualitative research. International Journal of Drug Policy. DOI: 10.1016/j.drugpo.2019.11.015.
- Van de Ven, K., Mulrooney, K., & Thomas, N. (2019). As drug deaths rise in rural Australia, we must do more to prevent overdoses..
- Mulrooney, K., & Van de Ven, K. (2019). ‘The Fittest on Earth’: Performance and Image Enhancing Drugs Use Within UK CrossFit Communities. DOI: 10.1007/978-3-030-17736-2_9.
- Van de Ven, K., Mulrooney, K., & Mcveigh, J. (2019). Human Enhancement Drugs. Routledge.
- Mulrooney, K., Van de Ven, K., Mcveigh, J., & Collins, R. (2019). Steroid Madness- Has the dark side of anabolic-androgenic steroids (AAS) been over-stated?.